Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C., talks about the problems associated with generic HIV PrEP drug markups and potential ways to fix it.

Big Pharma is again raising the prices for key medications that could save the lives of millions in Georgia and there are still more hikes to come.

By Taylor Sisk for KFF Health News. Broadcast version by Nadia Ramlagan for West Virginia News Service reporting for the KFF ...

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

Conservative Christian business owners believe that covering HIV prevention medication violates their freedom of religion ...

The Supreme Court will hear a challenge to Obamacare’s preventive care mandates, giving Trump a chance to reshape rules on ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

the HIV medication Biktarvy and the cancer drug Xtandi. The list price on Merck's diabetes drug Janumet increased 293% since it hit the market in 2007, the largest increase among all 25 drugs ...

That needs to go much beyond this licensing that was already signed. We also have long-acting cabotegravir [a drug used for the treatment of HIV/AIDS], which … has been available for four years now.

It usually happens when someone has AIDS. Drugs that treat HIV and related infections can also trigger rashes. These often go away several days or weeks after you stop taking the drug. Talk with ...

Antiretroviral therapy, first introduced with the FDA’s approval of AZT in 1987, was a turning point in HIV treatment. Over 50 antiretroviral drugs are now FDA-approved, offering a range of ...